Deferasirox methyl ester-d3
CAS: 1266741-05-2
Ref. 3D-RAC74105
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 27 Jun 2024
Product Information
Name:
Deferasirox methyl ester-d3
CAS:
Description:
Deferasirox methyl ester-d3 is a cyclic ester compound. It is an iron chelator that has been shown to be effective in the process of removing excess iron from patients with thalassemia, a blood disorder. Deferasirox was developed by Novartis and is approved for use in Europe and the United States. This drug has no adverse effects on the body, but it can cause some side effects such as nausea, vomiting, diarrhea, and headache. These symptoms are usually mild and temporary.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
387.4 g/mol
Formula:
C22H17N3O4
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 3D-RAC74105 Deferasirox methyl ester-d3
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
